Atopix Therapeutics
Privately held, clinical-stage, biopharmaceutical company based in oxford, uk.
Financials
Estimates*
| EUR | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m |
| % growth | - | 178 % | (50 %) | (15 %) | 68 % |
| EBITDA | (2.2m) | (2.8m) | (5.4m) | (3.9m) | <1m |
| % EBITDA margin | (798 %) | (367 %) | (1426 %) | (1209 %) | 122 % |
| Profit | (2.5m) | (3.0m) | (5.6m) | (4.1m) | <1m |
| % profit margin | (926 %) | (402 %) | (1472 %) | (1274 %) | 131 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Spinout | ||
| N/A | $1.7m | Grant | |
N/A | Series A | ||
£3.3m | Debt | ||
N/A | Acquisition | ||
| Total Funding | €1.5m | ||